AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1463361
Drug: Long course
RxNorm normalized name: long pepper extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long course DEC treatment (6, 7, 8, 9 or 10 mg kg‐1 b.w. divided into three doses daily for seven days)
Trial: 1463361
Drug: Short course
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short course DEC treatment (15 mg kg‐1 b.w. once daily for one, two or three days)
Trial: 1463361
Drug: DEC treatment
RxNorm normalized name: Zodryl DEC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DEC treatment for Brugia malayi infections
Trial: 1463361
Drug: DEC treatment
RxNorm normalized name: Zodryl DEC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DEC treatment for mixed infections
Trial: 1463361
Drug: DEC treatment
RxNorm normalized name: Zodryl DEC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DEC treatment for Wuchereria bancrofti infections
Trial: 31012786
Drug: Non-malaria control
RxNorm normalized name: Plasmodium malariae
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-malaria control vaccine (C3C)
Trial: 31012786
Drug: Non-malaria control
RxNorm normalized name: Plasmodium malariae
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-malaria control vaccine
Trial: 29315079
Drug: Spermidine supplementation
RxNorm normalized name: spermidine
DrugBank: Spermidine (DB03566)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spermidine supplementation (1.2 mg/day)
Trial: 17617289
Drug: Tizanidine capsule
RxNorm normalized name: Tizanidine Capsules
DrugBank: Tizanidine (DB00697)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tizanidine capsule (4 mg)
Trial: 17617289
Drug: Tizanidine tablet
RxNorm normalized name: Tizanidine Tablets
DrugBank: Tizanidine (DB00697)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tizanidine tablet (reference)
Trial: 17617289
Drug: Tizanidine capsule
RxNorm normalized name: Tizanidine Capsules
DrugBank: Tizanidine (DB00697)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tizanidine capsule and tablet
Trial: 15767241
Drug: Other statins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other statins (atorvastatin, simvastatin, pravastatin)
Trial: 12231416
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg oral clodronate
Trial: 12231416
Drug: 1600 mg
RxNorm normalized name: glycerin 1600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1600 mg oral clodronate
Trial: 12231416
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg intravenous clodronate
Trial: 10150325
Drug: Atenolol (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (120 mg/d orally)
Trial: 10150325
Drug: Ramipril (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ramipril (5 mg/d orally)
Trial: 2039377
Drug: Daily prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daily prednisone therapy (1.5 mg/kg per day and 0.75 mg/kg per day)
Trial: 796739
Drug: Alternate-day prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alternate-day prednisone therapy
Trial: 2039377
Drug: Daily prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daily prednisone therapy
Trial: 31090551
Drug: Multimodal prehabilitation
RxNorm normalized name: GLUTATHIONE 12.5 g in 100 mL ORAL LIQUID [K2LTS Brain Rehabilitation]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal prehabilitation program (in-hospital high-intensity endurance and strength training, high-protein nutrition and supplements, smoking cessation, psychological support)
Trial: 28071141
Drug: CHoBI7 intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CHoBI7 intervention (1-week handwashing with soap and water treatment)
Trial: 24158335
Drug: Mandibular two-implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mandibular two-implant overdentures (IOD)
Trial: 21130593
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose thiamine therapy
Trial: 11588903
Drug: 0 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g of ground flaxseed
Trial: 11588903
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g of ground flaxseed
Trial: 11588903
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g of ground flaxseed
Trial: 19271419
Drug: Imipramine 50
RxNorm normalized name: trimipramine 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine 50 mg daily
Trial: 2762082
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of visual and auditory input
Trial: 31400049
Drug: High-dose valacyclovir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose valacyclovir
Trial: 25601966
Drug: Capecitabine 800
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine 800 mg/m² twice daily throughout the 21-day cycle (Ccont)
Trial: 25601966
Drug: Capecitabine 1,250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capecitabine 1,250 mg/m² twice daily for 2 weeks on and 1 week off (Cint)
Trial: 24009092
Drug: Low-dose chest
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose chest CT (LDCT)
Trial: 24009092
Drug: Low-dose chest
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose chest CT (LDCT) with PSFR cutoffs
Trial: 23106890
Drug: Losartan 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 150 mg daily
Trial: 9269694
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg daily
Trial: 16630454
Drug: rhBNP (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhBNP (0.15 microg/kg bolus intravenous injection followed by 0.0075 microg.kg(‐1).min(‐1) for 24 hours, n = 105)
Trial: 16630454
Drug: NIT (starting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NIT (starting at 10 microg/min and increasing 5 microg/min each time till clinical effective dose for 24 hours, n = 104)
Trial: 9032580
Drug: Flosulide (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flosulide (20 mg twice a day)
Trial: 3538843
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g protein
Trial: 15486961
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g glucose
Trial: 3538843
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g protein + 50 g glucose
Trial: 26957232
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no treatment applied on frozen embryo before transfer)
Trial: 24632110
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT) for SAD, 16 weekly sessions of individual CBT.
Trial: 19781591
Drug: CPP-ACP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPP-ACP treatment (Tooth Mousse, GC Corp.) for 60 min x 7 days with 2-step self-etching primer adhesive (Clearfil SE Bond, Kuraray Medical)
Trial: 19781591
Drug: CPP-ACP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CPP-ACP treatment (Tooth Mousse, GC Corp.) for 60 min x 7 days with 'all-in-one' adhesive (G-Bond, GC Corp.)
Trial: 19781591
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (untreated dentine) with 2-step self-etching primer adhesive (Clearfil SE Bond, Kuraray Medical)
Trial: 19781591
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (untreated dentine) with 'all-in-one' adhesive (G-Bond, GC Corp.)
Trial: 19563393
Drug: Simvastatin 80
RxNorm normalized name: simvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 80 mg daily (S80)
Trial: 18441323
Drug: Ezetimibe 10
RxNorm normalized name: ezetimibe 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe 10 mg and simvastatin 10 mg daily (E10/S10)
Trial: 10089069
Drug: Regimen A
RxNorm normalized name: CHLOROXYLENOL 5 g in 1000 mL TOPICAL SOAP [REGIMEN ANTIMICROBIAL]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen A (THP‐COP) containing pirarubicin (30 mg/m2; day 1)
Trial: 10089069
Drug: Regimen B
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen B (modified CHOP) containing doxorubicin (30 mg/m2; day 1)
Trial: 10089069
Drug: Regimen C
RxNorm normalized name: ASPIRIN 81 mg ORAL TABLET, CHEWABLE [Bayer Aspirin Regimen Chewable Low Dose Aspirin Orange]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen C (THP‐COPE) including etoposide (80 mg/m2; day 1) in addition to regimen A
Trial: 7744384
Drug: Acetaminophen oral
RxNorm normalized name: acetaminophen Oral Film
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen oral drop (1000 mg)
Trial: 7744384
Drug: Acetaminophen tablet
RxNorm normalized name: Acetaminophen Tablets
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen tablet (1000 mg)
Trial: 2721259
Drug: terbutaline, 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: terbutaline, 15 mg daily for five weeks
Trial: 24949564
Drug: Naltrexone (NTX;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone (NTX; 25 mg once daily)
Trial: 23507293
Drug: Cognitive Behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioural Therapy (CBT) - three manualized sessions including one physical activity exposure session
Trial: 15596721
Drug: Midazolam injection
RxNorm normalized name: midazolam Injection
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Midazolam injection
Trial: 9004057
Drug: Clozapine 300
RxNorm normalized name: clozapine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clozapine 300 mg or 600 mg
Trial: 7680833
Drug: Cortisol infusion
RxNorm normalized name: cortisol succinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol infusion (2 micrograms.kg‐1.min‐1)
Trial: 3925746
Drug: Intravenous isosorbide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous isosorbide dinitrate (ISDN)
Trial: 30732125
Drug: Apatinib (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apatinib (500 mg/d) + chemotherapy
Trial: 30732125
Drug: Apatinib +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apatinib + chemotherapy
Trial: 25156125
Drug: No subgingival
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No subgingival treatment (NT)
Trial: 19346194
Drug: HT treatment
RxNorm normalized name: Night Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HT treatment group (2 mg 17beta‐estradiol + 1 mg norethisterone acetate)
Trial: 16940448
Drug: Acipimox (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acipimox (250 mg thrice daily)
Trial: 15234826
Drug: Thyroid-stimulating hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyroid-stimulating hormone (TSH) testing
Trial: 18476190
Drug: Grepafloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grepafloxacin (400 mg, single oral dose)
Trial: 18476190
Drug: Cefixime (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime (400 mg, single oral dose)
Trial: 21840169
Drug: Video-enhanced voice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Video-enhanced voice therapy using portable digital media players with clinician and self-videos
Trial: 21840169
Drug: Standard of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard of care voice therapy with written homework descriptions
Trial: 16455288
Drug: Oral Balance
RxNorm normalized name: Biotene Oral Balance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Balance gel delivered by slow release via a novel intra‐oral device
Trial: 16455288
Drug: Oral Balance
RxNorm normalized name: Biotene Oral Balance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Balance gel in bolus form
Trial: 16455288
Drug: Oral Balance
RxNorm normalized name: Biotene Oral Balance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Balance gel (both forms)
Trial: 8855797
Drug: Flutamide, testolactone,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide, testolactone, reduced hydrocortisone dose (from 12.9 to 7.9 mg/m2 day), and fludrocortisone
Trial: 8855797
Drug: Hydrocortisone and
RxNorm normalized name: hydrocortisone and mydriatics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone and fludrocortisone treatment
Trial: 1613128
Drug: verapamil (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: verapamil (120 mg every 8 hr)
Trial: 1613128
Drug: diltiazem (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diltiazem (90 mg every 8 hr)
Trial: 1613128
Drug: labetalol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: labetalol (200 mg every 12 hr)
Trial: 31246522
Drug: High-dose cytarabine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose cytarabine, daunorubicin, and etoposide (HD-ADE, n = 133)
Trial: 31246522
Drug: High-dose cytarabine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose cytarabine, daunorubicin, and etoposide (HD-ADE)
Trial: 20133929
Drug: Prednisolone 40
RxNorm normalized name: prednisolone 40 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone 40 mg for 7 days
Trial: 17394656
Drug: Hypothetical preventive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypothetical preventive drug treatment with heart attack postponement of 1 month
Trial: 17394656
Drug: Hypothetical preventive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypothetical preventive drug treatment with heart attack postponement of 6 months
Trial: 17394656
Drug: Hypothetical preventive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypothetical preventive drug treatment with heart attack postponement of 12 months
Trial: 17394656
Drug: Hypothetical preventive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypothetical preventive drug treatment with heart attack postponement of 2 years
Trial: 17394656
Drug: Hypothetical preventive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypothetical preventive drug treatment with heart attack postponement of 4 years
Trial: 17394656
Drug: Hypothetical preventive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypothetical preventive drug treatment with heart attack postponement of 8 years
Trial: 10469936
Drug: Botulinum A
RxNorm normalized name: Botulinum antitoxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum A toxin injections into the gastrocnemius muscle
Trial: 10469936
Drug: Saline vehicle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline vehicle injections into the gastrocnemius muscle
Trial: 30679414
Drug: ALEM plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALEM plus tacrolimus (TAC) monotherapy (Group A)
Trial: 30679414
Drug: ATG induction
RxNorm normalized name: ATGAM Injectable Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ATG induction plus TAC, mycophenolate mofetil (MMF) and steroids (Group B)
Trial: 17445098
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin type A (BoNTA) at doses of 110 to 260 U per treatment cycle
Trial: 15199622
Drug: Taizhi'an Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taizhi'an Capsule (TZA)
Trial: 11429346
Drug: CaCl(2) 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CaCl(2) 20 mg/kg and protamine 5 mg/kg mixed and infused over 10 min
Trial: 11429346
Drug: CaCl(2) 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CaCl(2) 10 mg/kg as a bolus followed by a 10‐min infusion of protamine 5 mg/kg and CaCl(2) 10 mg/kg
Trial: 8181345
Drug: 0.9 percent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9 percent saline solution (placebo)
Trial: 3948547
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) albuterol (250 micrograms)
Trial: 3948547
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) or subcutaneous albuterol (500 micrograms)
Trial: 3948547
Drug: Combined data
RxNorm normalized name: NO DATA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined data from all three albuterol routes
Trial: 3948547
Drug: Subcutaneous epinephrine
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Subcutaneous epinephrine (0.3 ml, 1:1,000)
Trial: 3948547
Drug: IV albuterol
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV albuterol (250 micrograms), IM albuterol (500 micrograms), or subcutaneous albuterol (500 micrograms)
Trial: 7020176
Drug: Prophylactic antithymocyte
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antithymocyte globulin (ATG) given in higher doses before signs of engraftment were evident.
Trial: 31869853
Drug: Melatonin 20
RxNorm normalized name: melatonin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 20 mg along with conventional treatment
Trial: 30307614
Drug: Sunscreen intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sunscreen intervention (SPF 15 applied at ≥ 2 mg cm−2)
Trial: 30307614
Drug: Typical sunscreen
RxNorm normalized name: benzocaine Mucous Membrane Topical Solution [Topicale]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Typical sunscreen use (own sunscreens applied at < 2 mg cm−2)
Trial: 19826197
Drug: Computational method
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computational method for incorporating patient motion into tomotherapy dose calculations
Trial: 17160199
Drug: Lutein (L)
DrugBank: Lutein (DB00137)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lutein (L) and zeaxanthin (Z) supplementation
Trial: 12560305
Drug: Tramadol 75
RxNorm normalized name: traMADol 75 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 75 mg plus droperidol 2.5 mg
Trial: 12560305
Drug: Tramadol 75
RxNorm normalized name: traMADol 75 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 75 mg plus clonidine 150 microg
Trial: 8652903
Drug: CsA in
RxNorm normalized name: CsA
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CsA in capsule form
Trial: 2011617
Drug: 0 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 g L-Tryptophan
Trial: 2011617
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g L-Tryptophan
Trial: 2011617
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g L-Tryptophan
Trial: 2011617
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g L-Tryptophan
Trial: 25559299
Drug: Stellate ganglion
RxNorm normalized name: Mastocarpus stellatus extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stellate ganglion block (SGB) with 10 mL of 1% lidocaine
Trial: 16169312
Drug: Enoxaparin, 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin, 100 IU/kg subcutaneously twice daily (n = 220)
Trial: 16169312
Drug: Tinzaparin, 175
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tinzaparin, 175 IU/kg subcutaneously once daily (n = 218)
Trial: 17270002
Drug: Tegaserod 6
RxNorm normalized name: tegaserod 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tegaserod 6 mg b.d.
Trial: 11564007
Drug: Tegaserod 2
RxNorm normalized name: tegaserod 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tegaserod 2 mg b.d.
Trial: 14616170
Drug: Tegaserod 2
RxNorm normalized name: tegaserod 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tegaserod 2 mg b.d. and Tegaserod 6 mg b.d.
Trial: 6347752
Drug: Verapamil 120
RxNorm normalized name: verapamil 120 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil 120 mg t.i.d.
Trial: 6125202
Drug: RX 781094
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RX 781094 at a dose of 0.1 mg/kg i.v.
Trial: 6125202
Drug: RX 781094
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RX 781094 at a dose of 0.05 mg/kg i.v.
Trial: 6125202
Drug: Clonidine at
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine at a dose of 0.1 mg and 0.2 mg i.v.
Trial: 25528523
Drug: Single-dose vaccination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose vaccination
Trial: 25528523
Drug: Three doses
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three doses in lifetime
Trial: 21716073
Drug: Dolutegravir 10
RxNorm normalized name: dolutegravir 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dolutegravir 10 mg
Trial: 23807273
Drug: Dolutegravir 25
RxNorm normalized name: dolutegravir 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dolutegravir 25 mg
Trial: 23807273
Drug: Efavirenz (control)
RxNorm normalized name: Efavirenz
DrugBank: Efavirenz (DB00625)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Efavirenz (control) 600 mg